Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT00151632
Eligibility Criteria:
Inclusion Criteria:
* Adults over 18 years of age
* Primary liver transplantation
* Immunosuppressive treatment associating tacrolimus and steroids at low doses (\< 20 mg/d)
* Written informed consent
Non-Inclusion Criteria:
* Pregnancy or ineffective contraception
* Immunosuppressive treatment
* Blood group incompatibility with the donor
* Autoimmune hepatitis
* Fulminant hepatitis
* Primary sclerosing cholangitis
* Combined transplantations
* Reduced liver
* Living donor
* Treated hypertension and/or diastolic pressure ≥ 90 mmHg and/or systolic pressure ≥ 140 mmHg,
* Acute or chronic renal failure(creatininemia ≥ 130 μmol/L) before transplantation
* Treated diabetes and/or fasting glycemia ≥ 7 mmol/L
* Treated hypercholesterolemia and/or cholesterolemia ≥ 7 mmol/L
* post-operative creatininemia ≥ 200 μmol/L
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00151632
Study Brief:
Protocol Section:
NCT00151632